Family Foundations for Special Education Trial (SS-SE)

February 6, 2026 updated by: Mark Feinberg, Penn State University

Family Foundations for Special Education

The goal of this clinical trial is to assess the program's impact on parent self-efficacy and co-parental support around (a) accessing health and educational services and (b) parenting for co-parents of children with disabilities entering the Special Education system before their first Individualized Education Program (IEP) meeting. The main questions it aims to answer are: Does the program improve co-parenting support and coordination and parent efficacy in accessing services for and parenting their child? Does the program improve parent mental health, service access, engagement, and adherence? Does the program improve parenting quality? Does the program improve child adjustment (mental and behavioral health, academic engagement)? Researchers will compare pretest and posttest questionnaires from Treatment Group A with Control Group B to see if the program improves parent and child well-being, co-parenting relations, relations with service providers, ability to access services and meaningfully participate in IEP and other meetings.

Participants will:

  • Complete pre- and post-test questionnaires
  • Treatment Group A will participate in 6 learning sessions, each 1 hour to 1½ hour long, over a 6-8 week period

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Samantha A. Murray-Perdue, PhD
  • Phone Number: 4199561701
  • Email: sxm1726@psu.edu

Study Locations

    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19102
        • Recruiting
        • Public Health Management Corporation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Parents/parental figures who are over the age of 18, and are involved in childrearing together.
  • Coparenting a child being evaluated for special education services
  • Has not yet had their first IEP meeting.
  • The target child must attend a Philadelphia elementary school (K-8).
  • The target child must be the first child in the family to go through the IEP process.
  • Co-parents must be fluent in English.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A
Group A will receive FF-SE in six virtual learning sessions to receive information on the special education system and methods to improve communications and working together as co-parents to enhance their IEP experience. The duration of each session will be between 1 to 1 ½ hour long and will be scheduled weekly according to the participants preferred scheduled. A workbook with supporting documents for each session will be mailed and/or emailed to each participant prior to the start of the sessions.
Families in the intervention group receive the new enhanced supports and participate in six private virtual learning sessions focused on understanding the special education system, improving communication, and enhancing collaboration as co-parents in the IEP process. Each session lasts 60-90 minutes and will be scheduled weekly according to the participants preferred schedule, including evenings and weekends. A workbook with supporting documents for each session will be sent to each participant prior to the start of the sessions.
Other Names:
  • FF-SE
No Intervention: Group B
Group B will have access to existing standard supports available to families entering the special education system.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Coparenting Relationship Questionnaire
Time Frame: From enrollment to the last learning session for intervention group, approximately 2 months after enrollment for the control group.
A validated, parent-report questionnaire on key dimensions of the coparenting relationship.
From enrollment to the last learning session for intervention group, approximately 2 months after enrollment for the control group.
Parenting Sense of Competence Scale
Time Frame: From pretest to two months post-intervention
Parent-reported, 17 item scale (Gibaud-Wallston & Wandersman, 1978) assessing parent self-efficacy in accessing services for their child. Higher scores reflect higher degree of sense of competence.
From pretest to two months post-intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 12, 2025

Primary Completion (Estimated)

March 31, 2026

Study Completion (Estimated)

December 30, 2026

Study Registration Dates

First Submitted

January 17, 2026

First Submitted That Met QC Criteria

February 6, 2026

First Posted (Actual)

February 10, 2026

Study Record Updates

Last Update Posted (Actual)

February 10, 2026

Last Update Submitted That Met QC Criteria

February 6, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY00025916
  • 218-23 (Other Grant/Funding Number: William Penn Foundation)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mental Health

Clinical Trials on Family Foundations for Special Education

Subscribe